Results 71 to 80 of about 6,419,132 (171)

Updated evidence on epidemiology, diagnosis, and treatment for colonic diverticular bleeding

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Since 2020, multiple large‐scale studies (CODE BLUE‐J) in Japan have accelerated the accumulation of evidence on colonic diverticular bleeding (CDB). This review summarizes the latest findings regarding CDB epidemiology and endoscopic hemostasis.
Chikamasa Ichita   +6 more
wiley   +1 more source

Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study

open access: yes, 2011
Aim. The standard therapeutic approach for symptomatic uncomplicated diverticular disease (DD) remains to be defined, and only a few studies have tested the efficacy of probiotics in these patients. Methods.
F. De Giorgi   +4 more
core   +2 more sources

Macrophage–microbiome–metabolite crosstalk in diverticular disease

open access: yesFrontiers in Cell and Developmental Biology
Diverticular disease is increasingly considered a dynamic disorder in which structural susceptibility of the colonic wall intersects with microbial ecology, mucosal immunity, and metabolic signaling.
Weihao Chen   +6 more
doaj   +1 more source

EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC

open access: yesПедиатрическая фармакология, 2008
Solvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the
article editorial
doaj   +2 more sources

Intestinal ultrasonography in the diagnosis and management of colonic diverticular disease

open access: yes, 2016
Diverticula of the colon and their symptomatic manifestations, including acute diverticulitis (AD), are frequent complaints and the cause of an increasing burden of ambulatory visits, diagnostic procedures, and hospital admissions.
G. Maconi, T. Guzowski, S. Carmagnola
core   +1 more source

The impact of 5-aminosalicylic acid and probiotic therapy on certain pathogenetic mechanisms of uncomplicated colonic diverticular disease

open access: yesJournal of V. N. Karazin Kharkiv National University: Series Medicine
Background. Colonic diverticular disease is a common condition with an age-related trend toward increasing prevalence. The influence of the gut microbiota on its course is substantial, as it may reflect specific pathways of disease development and serve ...
V.H. Mishchuk   +4 more
doaj   +1 more source

Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease

open access: yes, 2007
Aim: To comparatively ate the long term efficacy of Rifaximin and dietary fibers in reducing symptoms and/or complication frequency in symptomatic, uncomplicated diverticular disease. Methods: 307 patients (118 males, 189 females, age range: 40-80 years)
Vestito A   +7 more
core  

Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease

open access: yes, 2016
OBJECTIVE: The engagement of the gut microbiota in the development of symptoms and complications of diverticular disease has been frequently hypothesised.
SCAIOLI, ELEONORA   +12 more
core   +1 more source

Pathogenesis of diverticulosis and diverticular disease [PDF]

open access: yes, 2019
In this session different problems regarding the pathogenesis of diverticular disease were considered, including “Genetics”, “Neuromuscular function abnormalities”, “Patterns of mucosa inflammation”, and “Impact of lifestyle”.
Torti, Gabriele   +26 more
core   +1 more source

Home - About - Disclaimer - Privacy